FDA Adverse Event Injury Summary report: N

FLEXTEND

MDR report key: 1953779 · Received January 10, 2011

Report

Report Number
2124215-2010-24123
Event Type
Injury
Date Received
January 10, 2011
Date of Event
December 10, 2010
Report Date
January 11, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OK
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, INSPECTION OF THE LEAD BODY FOUND NO ANOMALIES. HOWEVER, TISSUE AND BLOOD WERE FOUND TO BE COAGULATED IN THE ELECTRODE TIP. ANALYSIS DID CONFIRM THAT THE LUMEN OF THE LEAD WAS COAGULATED CAUSING THE INSERTION OF THE STYLET TO BE DIFFICULT TO RE-IMPLANT. LABORATORY TESTING DID NOT IDENTIFY ANY LEAD CHARACTERISTICS THAT WOULD HAVE RESULTED IN THE CLINICAL OBSERVATION OF DISLODGEMENT. RESISTANCE AND PRESSURE TESTS WERE COMPLETED TO ASSESS LEAD ELECTRICAL PERFORMANCE AND INSULATION INTEGRITY. MEASUREMENTS THROUGHOUT THESE TESTS WERE WITHIN NORMAL LIMITS. MICROSCOPIC INSPECTIONS OF THE TERMINAL PIN ASSEMBLY, AND LEAD BODY AND FOUND NO ANOMALIES. LABORATORY TESTING WAS UNABLE TO REPRODUCE THE REPORTED CLINICAL OBSERVATIONS AND DETAILED ANALYSIS DID NOT REVEAL ANY ABNORMALITIES.

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT A REVISION PROCEDURE WAS PERFORMED DUE TO THE DISLODGMENT OF THIS ATRIAL (RA) LEAD. AN ATTEMPT TO REPOSITION THE LEAD WAS UNSUCCESSFUL. THIS LEAD WAS REMOVED AND REPLACED. NO ADVERSE PATIENT EFFECTS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FLEXTEND IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4087

Patients

Seq Age Sex Outcome Treatment
1 78 YR Required Intervention (B)(4)| (B)(4)| (B)(4)